ASCVD Risk estimator
The current tool is used to estimate the 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk. 

The ASCVD Risk Estimator is intended for patients without a prior atherosclerotic cardiovascular event or disease, between 40 and 79 years of age.

Contra-indications
The ASCVD Risk Estimator is not intended for patients who have already had an atherosclerotic cardiovascular event or disease. Further contra-indications may be found during the clinical evaluation.
 
Research authors: David C. Goff Jr., Donald M. Lloyd-Jones, Glen Bennett, Sean Coady, Ralph B. D'Agostino, Raymond Gibbons, Philip Greenland, Daniel T. Lackland, Daniel Levy, Christopher J. O'Donnell, Jennifer G. Robinson, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith Jr., Paul Sorlie, Neil J. Stone, Peter W.F. Wilson
Version: 1.22
  • Public
  • Cardiology
  • {{ modelType }}
V-1.22-2903.24.05.31
(01)08719327522783(8012)v1.22(4326)240531(240)2903
Download the User manual and consult the Intended purpose.

{{section.title}}

Calculate the result

Set more parameters to perform the calculation

10-year ASCVD Risk is: %

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

The result of the ASCVD Risk Estimator can be used to inform a dialogue between a physician and their patient about their risk of cardiovascular disease, and guide discussions surrounding risk-reducing interventions, such as life-style intervention or preventative medication.

The ASCVD Risk Estimator was originally derived in a US cohort of patients, and may overestimate or underestimate risks in other populations. However, its discriminative ability remains good (AUROC: 0.75 (95% CI: 0.74, 0.77))

When deciding upon the use of preventative medications such as statins, it is recommended to use not just the 10-year ASCVD Risk, but also look at the individual risk factors for a patient. Precise risk categories depend and vary based upon the target population and the local guidance organisation, but risks above 10% are generally considered high, and risks above 20% very high.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

Underlying models Part of
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}


Evidencio Community Account Benefits


With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.


Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Evidencio v3.29 © 2015 - 2024 Evidencio. All Rights Reserved